NIH-funded research R01 grant

Using engineered heart organoids to improve heart repair

Official title: Silicon nanowire engineered human isogenic cardiac organoids for heart repair

Funded at Clemson University · NIH-11050407 · Data updated 2026-11-12

This study is exploring a new way to help heal damaged hearts by creating tiny heart-like structures from human cells that can grow blood vessels and work better when put into injured hearts, which could offer new hope for patients recovering from heart problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startDecember 23, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$580,863
NIH project number1R01HL173532-01A1
Project IDNIH-11050407 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have experienced heart injuries or infarctions and are seeking advanced treatment options.

Less likely to help

Patients with non-cardiac conditions or those who do not have significant heart damage may not benefit from this research.

What this research studies

This research focuses on developing advanced heart organoids made from human stem cells to enhance recovery after heart injuries. The team is creating prevascularized cardiac organoids that incorporate silicon nanowires to improve cell survival and function when implanted in damaged hearts. By using a specific drug to enhance blood vessel formation, the goal is to ensure these organoids integrate better and provide significant functional recovery. Patients may benefit from this innovative approach to heart repair, which aims to overcome limitations of current treatments.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for heart repair, significantly improving recovery outcomes for patients with heart injuries.

How similar studies have gone: Previous research has shown promise in using stem cell-derived therapies for heart repair, but this approach with engineered organoids is relatively novel.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Mei, Ying — Clemson University
  • Study coordinator: Mei, Ying

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.